Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 1593853)

Published in Kidney Int on January 01, 1992

Authors

K G Koenig1, J S Lindberg, J E Zerwekh, P K Padalino, H M Cushner, J B Copley

Author Affiliations

1: Department of Internal Medicine, William Beaumont Army Medical Center, El Paso, Texas.

Articles citing this

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res (2011) 2.56

Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol (2008) 2.47

Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. Am J Kidney Dis (2014) 2.23

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int (2012) 1.27

Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol (2010) 1.25

Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol (2011) 1.09

Free 25(OH)D and the Vitamin D Paradox in African Americans. J Clin Endocrinol Metab (2015) 1.06

25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol (2013) 1.01

Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol (2010) 1.00

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol (2013) 0.94

Impaired vitamin D metabolism in CKD. Semin Nephrol (2013) 0.86

A review on vitamin d deficiency treatment in pediatric patients. J Pediatr Pharmacol Ther (2013) 0.85

Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis. Pediatr Nephrol (2011) 0.83

Relationship between vitamin D and muscle size and strength in patients on hemodialysis. J Ren Nutr (2007) 0.83

Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study. Pediatr Nephrol (2014) 0.77

Calcium balance and negative impact of calcium load in peritoneal dialysis patients. Perit Dial Int (2014) 0.77

The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4-5: the CKD-ROUTE study. Clin Exp Nephrol (2016) 0.76

Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS One (2017) 0.75

Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. Am J Kidney Dis (2017) 0.75

Articles by these authors

Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet (1996) 5.95

Skill acquisition in the implementation of functional analysis methodology. J Appl Behav Anal (2000) 5.39

Cardiac atrophy after bed rest and spaceflight. J Appl Physiol (1985) (2001) 3.04

Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem (1996) 1.80

Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med (1984) 1.67

Analysis of activity preferences as a function of differential consequences. J Appl Behav Anal (1999) 1.51

Assay of urinary oxalate: six methodologies compared. Clin Chem (1983) 1.44

A 26-year-old man with kidney allograft failure and foot pain. Am J Kidney Dis (2001) 1.39

The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab (1982) 1.36

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int (1996) 1.34

The potential role of salt abuse on the risk for kidney stone formation. J Urol (1993) 1.31

Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality. Chest (1987) 1.26

The admission urinalysis: impact on patient care. J Gen Intern Med (1986) 1.22

The quality of life of hemodialysis and transplant patients. Kidney Int (1982) 1.22

Exercise-induced amenorrhea and bone density. Ann Intern Med (1984) 1.12

A component analysis of "stereotypy as reinforcement" for alternative behavior. J Appl Behav Anal (2000) 1.08

Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest (1981) 1.08

Rapid enhancement of chick intestinal DNA-dependent RNA polymerase II activity by 1 alpha, 25-dihydroxyvitamin D3, in vivo. Proc Natl Acad Sci U S A (1974) 1.06

Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol (1986) 1.06

Attending rounds: a survey of physician attitudes. J Gen Intern Med (1990) 1.06

Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res (1995) 1.04

An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab (1979) 1.04

Increased intestinal chromatin template activity. Influence of 1alpha,25-dihydroxyvitamin D3 and hormone-receptor complexes. J Biol Chem (1976) 1.02

Biochemical changes associated with the symptomatic human intervertebral disk. Clin Orthop Relat Res (1993) 1.02

Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol Endocrinol (1996) 1.02

Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res (2000) 1.01

Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int (2007) 1.01

Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab (1989) 0.99

Relationship of estrogen and pregnancy to calcium homeostasis in pseudohypoparathyroidism. J Clin Endocrinol Metab (1986) 0.98

Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology (1984) 0.98

Expression of aromatase in the human growth plate. J Mol Endocrinol (2001) 0.97

Allergic bronchopulmonary aspergillosis: a case report and comment on reliability of testing sources. Ann Allergy (1984) 0.96

Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. J Clin Invest (1983) 0.94

Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endocrinol Metab (1980) 0.93

Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency. Gastroenterology (1983) 0.92

Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3. Proc Natl Acad Sci U S A (1973) 0.92

Increased vertebral bone mineral in response to reduced exercise in amenorrheic runners. West J Med (1987) 0.92

Improving house staff ordering of three common laboratory tests. Reductions in test ordering need not result in underutilization. Med Care (1987) 0.91

Bone ingrowth into porous calcium phosphate ceramics: influence of pulsing electromagnetic field. J Orthop Res (1988) 0.91

Viscous carboxymethylcellulose in the prevention of epidural scar formation. Spine (Phila Pa 1976) (1991) 0.90

Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab (1988) 0.90

A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab (1981) 0.90

Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. Hypertension (1997) 0.89

Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am J Med (1978) 0.89

Anabolic effects of fluoride on bone. Trends Endocrinol Metab (1995) 0.88

Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications. J Vasc Surg (2001) 0.88

Tumoral calcinosis: evidence for concurrent defects in renal tubular phosphorus transport and in 1 alpha,25-dihydroxycholecalciferol synthesis. Calcif Tissue Int (1980) 0.88

Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Am J Kidney Dis (1998) 0.87

Extra-renal production of 24,25-dihydroxyvitamin D in chronic renal failure during 25 hydroxyvitamin D3 therapy. Kidney Int (1983) 0.87

Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab (1985) 0.87

Role of volume depletion in the glycerol model of acute renal failure. Am J Physiol (1986) 0.86

Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers. Urology (1995) 0.85

Slow-release sodium fluoride in osteoporosis. J Bone Miner Res (1996) 0.85

Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Metabolism (1980) 0.85

Bone phenotype of the aromatase deficient mouse. J Steroid Biochem Mol Biol (2001) 0.84

Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med (1983) 0.84

Paricalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind, multicenter, randomized study. Am J Kidney Dis (2001) 0.84

Peritoneoscopic placement of Swan neck peritoneal dialysis catheters. Perit Dial Int (1994) 0.84

Interdependence of skeletal sclerosis and elevated circulating levels of 1,25-dihydroxyvitamin D in osteopetrotic (op and tl) rats. Bone (1995) 0.84

Granular tricalcium phosphate in large cancellous defects. Ann Clin Lab Sci (1987) 0.84

1Alpha-hydroxyvitamin D3. An analog of vitamin D which apparently acts by metabolism to 1alpha, 25-dihydroxyvitamin D3. Biochemistry (1974) 0.82

Characterization of osteoporosis in a patient with Werner's syndrome. J Am Geriatr Soc (1992) 0.82

Xanthogranulomatous pyelonephritis in a renal allograft recipient. Am J Kidney Dis (1997) 0.82

1,25-Dihydroxyvitamin D3: mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside from Solanum malacoxylon. Calcif Tissue Res (1977) 0.82

Different effects of mechanical vibration on bone ingrowth into porous hydroxyapatite and fracture healing in a rabbit model. J Orthop Res (1989) 0.82

Effect of chronic vitamin D deficiency on chick heart mitochondrial oxidative phosphorylation. J Mol Cell Cardiol (1981) 0.82

Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups. J Clin Endocrinol Metab (1983) 0.81

Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by urate salts. Kidney Int (1983) 0.81

Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards. J Urol (1979) 0.81

Human placental production of 1 alpha,25-dihydroxyvitamin D3: biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism. J Clin Endocrinol Metab (1986) 0.80

Partial biochemical and physicochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects. Kidney Int (1982) 0.80

Plasma-cell granuloma producing calcitriol and hypercalcemia. Ann Intern Med (1986) 0.80

Review: Renal osteodystrophy--pathogenesis and treatment. Am J Med Sci (1986) 0.80

Transabdominal angio-access catheter for long-term hemodialysis. Ann Intern Med (1984) 0.79

Examination of several techniques for predicting trabecular elastic modulus and ultimate strength in the human lumbar spine. Clin Biomech (Bristol, Avon) (1994) 0.79

Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF. Kidney Int (1988) 0.79

Utility and limitation of calciuric response to oral calcium load as a measure of intestinal calcium absorption: comparison with isotopic fractional calcium absorption. Invest Urol (1981) 0.79

Low-dose prednisone therapy in rheumatoid arthritis: effect on vitamin D metabolism. Arthritis Rheum (1984) 0.79

'Idiopathic' hematuria. A prospective evaluation. Arch Intern Med (1987) 0.79

Hemolytic-uremic syndrome without evidence of microangiopathic hemolytic anemia on peripheral blood smear. South Med J (1996) 0.79

Does hemodilution exist? Effects of saline infusion on hematologic parameters in euvolemic subjects. South Med J (1996) 0.78

Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis. J Bone Miner Res (1986) 0.78

Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. J Clin Endocrinol Metab (1984) 0.78

Connectivity in human cancellous bone by three-dimensional magnetic resonance imaging. Med Phys (1997) 0.78

Sexual dysfunction in the male dialysis patient: pathogenesis, evaluation, and therapy. Am J Kidney Dis (1986) 0.78

Measurement of mechanical properties of bone material in vitro by ultrasound reflection: methodology and comparison with ultrasound transmission. J Bone Miner Res (1991) 0.77

Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis. J Clin Endocrinol Metab (1980) 0.77

A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration. J Clin Endocrinol Metab (1979) 0.77

The risks of exercise. Adv Ren Replace Ther (1999) 0.77

Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am J Nephrol (1990) 0.77

Vitamin D-dependent intestinal calcium absorption. Gastroenterology (1979) 0.77

Nontransplant therapy for dialysis-related amyloidosis. Semin Dial (2001) 0.77

Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism. J Clin Endocrinol Metab (1979) 0.77

Fluoride-stimulated [3H]thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor beta. J Bone Miner Res (1993) 0.76

Isolated asymptomatic hematuria in the adult. Am J Med Sci (1986) 0.76

New vitamin D analogs. Semin Dial (2001) 0.76

Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients. Arch Intern Med (1992) 0.76

Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism. J Clin Endocrinol Metab (1989) 0.76